Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01490151 · ClinicalTrials.gov registry record · NA
Medtronic Treat to Range (TTR) Closed-Loop Control
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01490151: Completed NA study, sponsored by Stanford University.
NCT01490151 is a NA study that has completed, run by Stanford University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01490151, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a treat-to-range automated insulin management system using continuous glucose monitoring (CGM) and subcutaneous insulin pump infusion in individuals with type 1 diabetes.
Interventions
- DEVICE TTR controller (Medtronic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01490151
The ClinicalTrials.gov registry entry for NCT01490151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TTR controller (Medtronic) is the first listed.
NCT01490151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01490151 about?
NCT01490151 is a clinical study titled "Medtronic Treat to Range (TTR) Closed-Loop Control". The purpose of this study is to evaluate a treat-to-range automated insulin management system using continuous glucose monitoring (CGM) and subcutaneous insulin pump infusion in individuals with type 1 diabetes.
What is the current status of trial NCT01490151?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2011-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01490151?
The interventions under investigation include: TTR controller (Medtronic) (DEVICE).
Who is sponsoring clinical trial NCT01490151?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.